| scholarly article | Q13442814 |
| P2093 | author name string | Sheng Zhang | |
| Xiaoyu Yang | |||
| Tianhong Yu | |||
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases | Q26766640 | ||
| Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications | Q26796244 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity | Q28508698 | ||
| Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
| Matrine induces apoptosis in angiotensin II-stimulated hyperplasia of cardiac fibroblasts: effects on Bcl-2/Bax expression and caspase-3 activation | Q33288100 | ||
| Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy | Q33929939 | ||
| MicroRNAs and the regulation of fibrosis | Q34238322 | ||
| The pathogenesis of cardiac fibrosis. | Q37161329 | ||
| miR-489 inhibits silica-induced pulmonary fibrosis by targeting MyD88 and Smad3 and is negatively regulated by lncRNA CHRF. | Q37163179 | ||
| MicroRNAs: novel regulators in cardiac development and disease | Q37176880 | ||
| Emerging concepts in cardiac matrix biology | Q37661389 | ||
| Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases | Q37838705 | ||
| Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β. | Q37924999 | ||
| Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease | Q38040163 | ||
| Fibrosis and heart failure | Q38057701 | ||
| Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis | Q38758959 | ||
| MicroRNAs in metabolism. | Q38786731 | ||
| MicroRNA-506-3p regulates neural stem cell proliferation and differentiation through targeting TCF3. | Q38830094 | ||
| miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling | Q39413020 | ||
| Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms | Q40669724 | ||
| NF-κB mediated miR-26a regulation in cardiac fibrosis. | Q46054688 | ||
| Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF. | Q46481216 | ||
| Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding | Q46870302 | ||
| MicroRNA-148a Suppresses the Proliferation and Migration of Pancreatic Cancer Cells by Down-regulating ErbB3. | Q51125889 | ||
| MicroRNA Let-7i negatively regulates cardiac inflammation and fibrosis. | Q53384750 | ||
| Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart. | Q54589506 | ||
| Quercetin provides greater cardioprotective effect than its glycoside derivative rutin on isoproterenol-induced cardiac fibrosis in the rat. | Q54778852 | ||
| Endothelin receptors in cultured adult rat cardiac fibroblasts | Q72785732 | ||
| Molecular mechanisms of myocardial remodeling | Q77918078 | ||
| The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489 | Q87336307 | ||
| Effects of dynamic changes in histone acetylation and deacetylase activity on pulmonary fibrosis | Q89105027 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 2229-2235 | |
| P577 | publication date | 2020-01-23 | |
| P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
| P1476 | title | MicroRNA-489 suppresses isoproterenol-induced cardiac fibrosis by downregulating histone deacetylase 2 | |
| P478 | volume | 19 |
Search more.